Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial. Clin J Am Soc Nephrol. 2016 05 06; 11(5):803-811.

View in: PubMed

subject areas

Adult
Albuminuria
Antidiuretic Hormone Receptor Antagonists
Benzazepines
Disease Progression
Double-Blind Method
Female
Glomerular Filtration Rate
Humans
Hypernatremia
Hypertension
Kidney
Magnetic Resonance Imaging
Male
Middle Aged
Organ Size
Pain
Polycystic Kidney, Autosomal Dominant
Severity of Illness Index

authors with profiles

Arlene Chapman